Provided by Tiger Trade Technology Pte. Ltd.

Scinai Immunotherapeutics Ltd.

3.22
+0.28009.52%
Post-market: 3.270.0476+1.48%19:58 EDT
Volume:428.39K
Turnover:1.40M
Market Cap:1.66M
PE:-0.28
High:3.58
Open:3.20
Low:2.85
Close:2.94
52wk High:17.20
52wk Low:2.15
Shares:516.94K
Float Shares:435.64K
Volume Ratio:5.70
T/O Rate:98.34%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-11.3358
EPS(LYR):59.48
ROE:-29.19%
ROA:-35.85%
PB:0.27
PE(LYR):0.05

Loading ...

NASDAQ Trade Halt Continues Reason not Available at 07:55 Am

Reuters
·
Aug 21

Press Release: Scinai Strengthens CDMO Leadership with Appointment of Eran Kuratz as Head of Supply Chain and Business Process Administration

Dow Jones
·
Aug 10

Scinai Q1 FY26 returns to profit at USD 3.58 million; revenue falls to USD 489,000

Reuters
·
Jun 10

Press Release: Scinai Reports First Quarter 2026 Financial Results and Provides Corporate Update Highlighting Expansion of CDMO Platform and Advancement of Strategic Growth Initiatives

Dow Jones
·
Jun 10

Scinai names Eilon Elmalem site head of Yavne CDMO facility

Reuters
·
May 20

Press Release: Scinai Biopharma Services Appoints Eilon Elmalem as Site Head of Yavne CDMO Facility

Dow Jones
·
May 20

ADRs Advance; Scinai Immunotherapeutics Ltd. Climbs 62%

Dow Jones
·
Apr 25

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:37 AM

Reuters
·
Apr 24

Why Is Scinai Immunotherapeutics Stock (SCNI) Up Today?

TIPRANKS
·
Apr 24

Scinai Immunotherapeutics announces $2.61M private placement

TIPRANKS
·
Apr 24

Press Release: Scinai Immunotherapeutics Announces $2.61 Million Private Placement Financing

Dow Jones
·
Apr 24

Scinai Immunotherapeutics completes strategic reorganization

TIPRANKS
·
Apr 06

Scinai Immunotherapeutics FY EPS $(3.56), Sales $1.311M Up From $658.000K YoY

Benzinga Earnings
·
Apr 01

Scinai Immunotherapeutics highlights expanded CDMO platform

TIPRANKS
·
Mar 19

Press Release: Scinai Signs Second Amendment to PinCell Option Agreement and Submits Revised EUR12 Million Non-Dilutive FENG Application to Advance PC111 Through Human Proof of Concept

Dow Jones
·
Mar 02

ADRs Advance; Scinai Immunotherapeutics Ltd. Climbs 18%

Dow Jones
·
Feb 25